Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life

Isetts, 2003, Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals, Arch Intern Med, 163, 1813, 10.1001/archinte.163.15.1813 Mikeal, 1975, Quality of pharmaceutical care in hospitals, Am J Hosp Pharm, 32, 567 Smith, 1991, Levels of pharmaceutical care: a theoretical model, Am J Hosp Pharm, 48, 540 Hepler, 1990, Opportunities and responsibilities in pharmaceutical care, Am J Hosp Pharm, 47, 533 Medicare Payment Advisory Commission, Hackbarth GM (Chair). Report to the congress: Medicare coverage of nonphysician practitioners. Washington, DC, June 2002:21–6. Public Law No. 108-173: Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Bluml, 2000, Pharmaceutical care services and results in project impact: hyperlipidemia, J Am Pharm Assoc, 40, 157, 10.1016/S1086-5802(16)31059-2 Cranor, 2003, The Asheville Project: short-term outcomes of a community pharmacy diabetes care program, J Am Pharm Assoc, 43, 149, 10.1331/108658003321480696 Tsuyuki, 2002, A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. The study of cardiovascular risk intervention by pharmacists (SCRIP), Arch Intern Med, 162, 1149, 10.1001/archinte.162.10.1149 Erickson, 1997, Pharmacists' ability to influence outcomes of hypertension therapy, Pharmacotherapy, 17, 140 Shibley, 1997, Implementation of pharmaceutical care services for patients with dyslipidemias by independent community pharmacy practitioners, Ann Pharmacother, 31, 713, 10.1177/106002809703100608 Beney, 2004, Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review), issue 1 Leape, 1999, Pharmacist participation on physician rounds and adverse drug events in the intensive care unit, JAMA, 282, 267, 10.1001/jama.282.3.267 Kucukarslan, 2003, Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units, Arch Intern Med, 163, 2014, 10.1001/archinte.163.17.2014 Chiquette, 1998, Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs, Arch Intern Med, 158, 1641, 10.1001/archinte.158.15.1641 Kaushal, 2001, The clinical pharmacist's role in preventing adverse drug events Gattis, 1999, Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study, Arch Intern Med, 159, 1939, 10.1001/archinte.159.16.1939 Cranor, 2003, The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program, J Am Pharm Assoc, 43, 173, 10.1331/108658003321480713 Schumock, 2003, Evidence of the economic benefit of clinical pharmacy services—1996-2000, Pharmacotherapy, 23, 113, 10.1592/phco.23.1.113.31910 Johnson, 1997, Drug-related morbidity and mortality and the economic impact of pharmaceutical care, Am J Health Syst Pharm, 54, 554, 10.1093/ajhp/54.5.554 Schumock, 1996, Economic evaluation of clinical pharmacy service—1988-1995, Pharmacotherapy, 16, 1188 Hatoum, 1993, 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists, Ann Pharmacother, 27, 1106, 10.1177/106002809302700917 Hatoum, 1986, Eleven year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy, Drug Intell Clin Pharm, 20, 33, 10.1177/106002808602000105 Hammond, 2003, Collaborative drug therapy management by pharmacists—2003, Pharmacotherapy, 23, 1210, 10.1592/phco.23.10.1210.32752 Cipolle, 2004 Isetts, 1999, Use of a student-driven, university-based pharmaceutical care clinic to define the highest standards of patient care, Am J Pharm Educ, 63, 443 Agency for Healthcare Research and Quality National Committee for Quality Assurance National Committee for Quality Assurance Guyatt, 1993, Measuring health-related quality of life, Ann Intern Med, 118, 622, 10.7326/0003-4819-118-8-199304150-00009 Wiederholt, 1987, Development of an instrument to measure evaluative criteria that patients use in selecting a pharmacy for obtaining prescription drugs, J Pharm Mark Manage, 1, 35, 10.1300/J058v01n04_04 MacKeigan, 1989, Development and validation of an instrument to measure patient satisfaction with pharmacy services, Med Care, 27, 522, 10.1097/00005650-198905000-00007 Starfield, 1991, Ambulatory care groups: a categorization of diagnoses for research and management, Health Serv Res, 26, 53